ImmuCell Corporation - Payout Ratio History
Payout ratio history for stock ICCC (ImmuCell Corporation).
| Date | Payout ratio |
|---|---|
| December 2020 | -220.34% |
| November 2020 | -207.92% |
| October 2020 | -207.92% |
| September 2020 | -207.92% |
| August 2020 | -225.11% |
| July 2020 | -225.11% |
| June 2020 | -225.11% |
| May 2020 | -120.93% |
| April 2020 | -120.93% |
| March 2020 | -120.93% |
| February 2020 | -120.93% |
| January 2020 | -120.93% |
| December 2019 | -120.93% |
| November 2019 | -120.93% |
| October 2019 | -120.93% |
| September 2019 | -120.93% |
| August 2019 | -120.93% |
| July 2019 | -120.93% |
| June 2019 | -120.93% |
| May 2019 | -120.93% |
| April 2019 | -120.93% |
| March 2019 | -120.93% |
| February 2019 | -1300% |
| December 2018 | -1300% |
ICCC
Price: $5.03
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.75 USD
P/E Ratio: -6.41
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 8519
Ebitda: 1.2 millionMarket Capitalization: 40.1 million